Company intelligence / Profile preview

Regen Lab USA

Brooklyn, New York, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Regen Lab USA is a biotechnology company specializing in the development of autologous cell therapies and medical devices for tissue engineering and regenerative medicine. The company's core technology focuses on the preparation of Platelet-Rich Plasma (PRP) and its combination with Hyaluronic Acid (Cellular Matrix) for various clinical applications. Their products are widely used in orthopedics, sports medicine, dermatology, and aesthetic surgery to promote natural healing and tissue repair. Regen Lab USA provides standardized, closed-circuit systems that allow for the efficient and safe preparation of high-quality biologics at the point of care.

Therapeutic areas: RheumatologyDermatology
Modalities: Cell therapyDevice
Industry: Biotech

Beyond the preview

Go deeper on Regen Lab USA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regen Lab USA.

Explore the full profile